BARKAL CONSULTANTS LTD
- 86220Specialist medical practice activities
Opportunity 70/100 (strong), bankability 65/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (71/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · FRS 102Key financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · FRS 102| Metric | 2025-05-31 |
|---|---|
| Total assets | £35.7k |
| Current assets | £111.0k |
| Cash | £50.1k |
| Debtors | £60.8k |
| Net assets | £35.7k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
4 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Corporate timeline (4 events)Click to expand
- 2025-10-21📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-05-09🏢Company incorporatedAs BARKAL CONSULTANTS LTD
- 2024-05-09➕HASSAN, Mohammed Alhassan Abdulrahim appointeddirector
- 2024-05-09📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Young company: Only 2.0 years old — management layer unlikely to be developed.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanGroup structure
Barkal Holdings Ltd is the ultimate parent — holding 75%+ shares. This company sits inside their group.
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Barkal Holdings Ltd Corporate entity | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 09/05/2024 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · EH postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ARMOUR OF LIGHT LIMITED→ SC488863 · est 2014 · no financials extracted | — | — | — | — | 11y | — | — |
| ASHAKATA HEALTH CARE COMPANY LIMITED→ SC776769 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ASKA PSYCHOLOGIST LTD→ SC743888 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ASPEN TOWER SILVERSTONE PROPCO (QVH) LIMITED→ SC603160 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| AUSTERE MEDICAL SERVICES LTD→ SC756733 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| AVODAH CARE LTD→ SC726265 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| AWC HEALTHCARE LTD→ SC881660 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| AZAD PHARMA LTD→ SC725723 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| BALLANTINE GOLDIE LTD→ SC392228 · est 2011 · no financials extracted | — | — | — | — | 15y | — | — |
| BARRY DUNCAN EYECARE LIMITED→ SC830282 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| BELGRAVE MEDICAL LIMITED→ SC625781 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| BELLEVUE DENTAL PRACTICE (EDINBURGH) LTD→ SC381652 · est 2010 · no financials extracted | — | — | — | — | 15y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.